Vivelle-Dot .1 mg/d
estradiol · PATCH, EXTENDED RELEASE · Sandoz Inc
No Recall HistoryCurrently in Shortage
Plain English
Vivelle-Dot is a patch, extended release containing estradiol at .1 mg/d, taken transdermal. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- Vivelle-Dot
- Generic Name
- estradiol
- NDC Code (Product)
66758-149- Manufacturer
- Sandoz Inc
- Strength
- .1 mg/d
- Dosage Form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- NDA020538
- Drug Class
- Estrogen [EPC]
- Marketing Start
- 01/08/1999
Recall History
No Recall HistoryFrequently Asked Questions
What is Vivelle-Dot used for?
Vivelle-Dot contains estradiol. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.
Is Vivelle-Dot a controlled substance?
Vivelle-Dot is not classified as a controlled substance by the DEA.
What is the generic name for Vivelle-Dot?
The generic name for Vivelle-Dot is estradiol. There are 12 other brand versions of estradiol.
What is the NDC code for Vivelle-Dot .1 mg/d?
The NDC (National Drug Code) for Vivelle-Dot .1 mg/d is 66758-149, listed by Sandoz Inc.